logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Koutaro Yokote

chiba university

60H指数
644论文数
2.2W被引数
收录论文 258
发表时间
logo
Renal Safety of Intravitreal Ranibizumab and the Effects of SGLT2 Inhibition in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial糖尿病黄斑水肿中玻璃体内注射雷珠单抗的肾脏安全性及SGLT2抑制剂的影响：COMET试验的事后分析
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-09-10
err0
PREAI
errToshiki Sakai; Ryoichi Ishibashi; Masaya Koshizaka; Yoko Takatsuna; Tomoaki Tatsumi; Takayuki Baba; Kenichi Sakurai; Yoshiro Maezawa; Koutaro Yokote
err分享
err收藏
Sodium–Glucose Cotransporter 2 Inhibition in Diabetic Macular Oedema: Emerging Evidence for Stage-Dependent Systemic-Retinal Responsiveness钠-葡萄糖协同转运蛋白2在糖尿病黄斑水肿中的抑制作用：阶段依赖性系统性-视网膜反应的涌现证据
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-09-03
err0
PREAI
errRyoichi Ishibashi; Kiichi Hirayama; Toshiki Sakai; Tomoaki Tatsumi; Yoko Takatsuna; Takayuki Baba; Masaya Koshizaka; Koutaro Yokote
err分享
err收藏
Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial基线HDL胆固醇与SGLT2抑制剂在糖尿病黄斑水肿中对抗VEGF注射的节省效应：COMET试验的事后分析
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-08-28
err0
PREAI
errRyoichi Ishibashi; Masaya Koshizaka; Kiichi Hirayama; Toshiki Sakai; Tomoaki Tatsumi; Yoko Takatsuna; Takayuki Baba; Yoshiro Maezawa; Koutaro Yokote
err分享
err收藏
Association of GLP-1 Receptor Agonist Use With Cardiovascular Outcomes and Mortality in Japanese Patients With Type 2 Diabetes: A Real-World Claims Database StudyGLP-1受体激动剂使用与日本2型糖尿病患者心血管结局和死亡率的相关性：一项真实世界理赔数据库研究
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-08-12
err0
PREAI
errMasaya Koshizaka; Ryoichi Ishibashi; Tomoki Ishikawa; Kazuo Goda; Jumpei Sato; Masaru Kitsuregawa; Koutaro Yokote; Naohiro Mitsutake
err分享
err收藏
Ophthalmic Backgrounds Influencing the Efficacy of SGLT2 Inhibitor in Diabetic Macular Oedema: Post-hoc Analysis of the COMET Trial眼科背景因素对SGLT2抑制剂在糖尿病黄斑水肿中疗效的影响：COMET试验的事后分析
errdiabetes, obesity and metabolism
IF0
err2026-05-03
err0
PREAI
errRyoichi Ishibashi; Tomoaki Tatsumi; Masaya Koshizaka; Yoko Takatsuna; Tomomi Kaiho; Yosuke Nakamura; Noriko Asaumi; Kiichi Hirayama; Takayuki Baba; Koutaro Yokote
err分享
err收藏
Efficacy for LDL-C–lowering and Safety of Pemafibrate Extended-release Formulation in Patients with Statin-intolerant Hypercholesterolemia: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group trial
errJournal of Clinical Lipidology
IF4.6
err2026-01-22
err0
errOAAI
errShizuya Yamashita; Eiichi Araki; Hidenori Arai; Koutaro Yokote; Ryohei Tanigawa; Keisuke Kunitomi; Kaho Ikegami; Hideki Suganami; Masaya Tanahashi; Sara Minamikawa; Shun Ishibashi
err分享
err收藏
Little Evidence of Atherosclerosis in a Middle-Aged Japanese Woman with Familial Hypercholesterolemia Carrying PCSK9 (p.Glu32Lys) and ABCG8 (p.Ile419Asn) Variants Despite Elevated Lipoprotein(a) Levels一名患有家族性高胆固醇血症的中年日本女性，尽管载脂蛋白(a)水平升高，但携带PCSK9 (p.Glu32Lys)和ABCG8 (p.Ile419Asn)变异，其动脉粥样硬化证据较少。
errINTERNAL MEDICINE
IF1.1
err2025-12-01
err0
PREAI
errAono, Kazuto; Kobayashi, Junji; Tada, Hayato; Maezawa, Yoshiro; Yokote, Koutaro
err分享
err收藏
Hypoxia, iron, and ferroptosis: a novel perspective on pheochromocytoma progression and therapy缺氧、铁和 ferroptosis：对嗜铬细胞瘤进展和治疗的全新视角
errEUROPEAN JOURNAL OF ENDOCRINOLOGY
IF5.2
err2025-12-01
err0
PREAI
errRuike, Yutaro; Suzuki, Sawako; Hashimoto, Rei; Sugo, Masafumi; Watanabe, Suzuka; Igarashi, Katsushi; Ishiwata, Kazuki; Naito, Kumiko; Ishida, Akiko; Fujimoto, Masanori; Koide, Hisashi; Imamura, Yusuke; Sakamoto, Shinichi; Ichikawa, Tomohiko; Takahashi, Kohei; Ozawa, Yoshihito; Ikeda, Jun-ichiro; Yokote, Koutaro
err分享
err收藏
Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome-A case reportSGLT2抑制剂在治疗维尔纳综合征中的胰岛素抵抗和高血压糖的疗效与安全性——病例报告
errJOURNAL OF DIABETES INVESTIGATION
IF3
err2025-11-01
err0
errOAAI
errYagi, Takashi; Aotani, Daisuke; Hasegawa, Chie; Shimizu, Yuki; Koyama, Hiroyuki; Maezawa, Yoshiro; Yokote, Koutaro; Tanaka, Tomohiro
err分享
err收藏
PS13.4: Autologous transplantation of LCAT gene-transduced adipocytes enabled long-term LCAT replacement in a patient with LCAT deficiency in first in human clinical trial.PS13.4: 自体转导LCAT基因的脂肪细胞移植使得在首个人类临床试验中，一名LCAT缺乏症患者实现了长期LCAT替代。
errTransplantation
IF5
err2025-10-20
err0
PREAI
errKuroda, Masayuki; Wada, Jun; Masezawa, Yoshiro; Kubota, Yoshitaka; Mitsukawa, Nobuyuki; Yasunaga, Kunio; Yamamoto, Tokuo; Aso, Masayuki; Hanaoka, Hideki; Saito, Yasushi; Yokote, Koutaro
err分享
err收藏
Clinical obesity and Himan-sho (obesity disease): Lessons from Japan's 25 years of experience toward a new era of obesity care临床肥胖与Himan-sho（肥胖疾病）：来自日本25年经验的经验教训，以迈向肥胖护理的新时代
errJournal of Diabetes Investigation
IF3
err2025-10-16
err0
errOAAI
errWataru Ogawa; Iichiro Shimomura; Toshimasa Yamauchi; Koutaro Yokote
err分享
err收藏
Redox-dependent liver gluconeogenesis impacts different intensity exercise in mice氧化还原依赖性肝脏糖异生影响不同强度运动在小鼠中的表现
errNature Metabolism
IF20.8
err2025-09-18
err0
errOAAI
errTakahiro Horiuchi; Keizo Kaneko; Shinichiro Hosaka; Kenji Uno; Seitaro Tomiyama; Kei Takahashi; Maya Yamato; Akira Endo; Hiroto Sugawara; Yohei Kawana; Yoichiro Asai; Shinjiro Kodama; Junta Imai; Seiya Mizuno; Satoru Takahashi; Atsushi Takasaki; Hiraku Ono; Koutaro Yokote; Rae Maeda; Yuki Sugiura; Hideki Katagiri
err分享
err收藏
A Case of Acquired LCAT Deficiency with the Discrepancy between Spontaneous Resolution of Proteinuria and Continually Low HDL Cholesterol Levels1例获得性LCAT缺乏症病例，其特点为蛋白尿自发缓解与持续低HDL胆固醇水平之间的差异。
errJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
IF2.8
err2025-09-01
err0
errOAAI
errMatsuo, Miki; Ogura, Masatsune; Kuroda, Masayuki; Arisato, Tetsuya; Kishida, Masatsugu; Harada-Shiba, Mariko; Wada, Jun; Yokote, Koutaro; Yoshihara, Fumiki
err分享
err收藏
Sodium-glucose co-transporter 2 inhibitors reduce the intravitreal anti-VEGF treatment necessity in eyes with early diabetic macular oedema: A post-hoc analysis focusing on the fellow eye of the COMET trialSodium-glucose co-transporter 2抑制剂可降低早期糖尿病黄斑水肿患眼对玻璃体内抗-VEGF治疗的需求：一项关注COMET试验对侧眼的回顾性分析
errdiabetes obesity metabolism
IF0
err2025-08-04
err0
PREAI
errTomoaki Tatsumi PhD; Yoko Takatsuna PhD; Ryoichi Ishibashi PhD; Masaya Koshizaka PhD; Tomomi Kaiho PhD; Toshiyuki Oshitari PhD; Yuki Shiko PhD; Noriko Asaumi MD; Shuichi Yamamoto PhD; Koutaro Yokote PhD; Takayuki Baba PhD
err分享
err收藏
Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemiaSETD1B催化域对MLL重排白血病中H3K4me3宽度和MYC表达量的调控
errLEUKEMIA
IF13.4
err2025-05-08
err0
errOAAI
errIzumi, Shintaro; Ohtani, Ko; Matsumoto, Makoto; Shibata, Seito; Rahmutulla, Bahityar; Fukuyo, Masaki; Nishimoto, Mitsutaka; Miyagawa, Hideo; Sakaida, Emiko; Yokote, Koutaro; Kitabayashi, Issay; Araki, Kimi; Kaneda, Atsushi; Hoshii, Takayuki
err分享
err收藏
Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-02-11
err0
errOAAI
errIshibashi, Ryoichi; Takatsuna, Yoko; Koshizaka, Masaya; Tatsumi, Tomoaki; Takahashi, Sho; Nagashima, Kengo; Ishikawa, Ko; Kaiho, Tomomi; Asaumi, Noriko; Baba, Takayuki; Yamamoto, Shuichi; Yokote, Koutaro; COMET Trial investigators
err分享
err收藏
Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study
errJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
IF2.8
err2025-02-01
err0
errOAAI
errIshibashi, Shun; Arai, Hidenori; Yokote, Koutaro; Araki, Eiichi; Watanabe, Mao; Nakanishi, Michiko; Makinose, Yuichi; Suganami, Hideki; Kurihara, Yuji; Yamashita, Shizuya
err分享
err收藏
Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights
errFRONTIERS IN ENDOCRINOLOGY
IF4.6
err2025-01-14
err0
errOAAI
errKitamoto, Takumi; Ruike, Yutaro; Koide, Hisashi; Inoue, Kosuke; Maezawa, Yoshiro; Omura, Masao; Nakai, Kazuki; Tsurutani, Yuya; Saito, Jun; Kuwa, Katsuhiko; Yokote, Koutaro; Nishikawa, Tetsuo
err分享
err收藏
Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub-analysis of a randomized controlled study
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-01-13
err0
PREAI
errHirayama, Kiichi; Koshizaka, Masaya; Ishibashi, Ryoichi; Shoji, Mayumi; Horikoshi, Takuro; Sakurai, Kenichi; Yokote, Koutaro; PRIME V Study Grp
err分享
err收藏
Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group Study
errJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
IF2.8
err2025-01-01
err0
errOAAI
errArai, Hidenori; Yamashita, Shizuya; Araki, Eiichi; Yokote, Koutaro; Tanigawa, Ryohei; Saito, Ayumi; Furukawa, Daisuke; Suganami, Hideki; Ishibashi, Shun
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Peter Libby
H 指数: 227 · 论文数: 1.3K
P
Paul M. Ridker
H 指数: 226 · 论文数: 1.4K
F
Frank J. Gonzalez
H 指数: 191 · 论文数: 1.7K
J
Johan Auwerx
H 指数: 183 · 论文数: 913
J
Julie E. Buring
H 指数: 179 · 论文数: 1.3K
查看更多